Base editing of human embryos sharpens precision and revives ethical debate
Scientists have used next-generation base-editing tools to alter DNA in human embryos with markedly higher accuracy than earlier CRISPR approaches, according to work reported in Nature. Unlike conventional CRISPR, which cuts both strands of DNA and can introduce unintended changes, base editors rewrite individual genetic letters without breaking the double helix, reducing collateral damage.
Using the method, researchers disabled the gene NANOG and found it is essential for human embryogenesis — embryos failed to develop normally without it — offering a window into the earliest stages of human development that animal models cannot fully capture. The embryos were studied in the lab and not implanted.
The advance cuts in two directions. As a research tool, more precise editing lets scientists probe the function of individual genes in early development, with implications for understanding infertility and miscarriage. But greater accuracy also narrows the technical gap to clinical use, and researchers cautioned that heritable editing of embryos intended for pregnancy remains scientifically premature and ethically contested, urging that the debate over governance keep pace with the capability.